Thoughts12 Jun 2026 16:36
Anyone got an opinion on the current status of the bid as it stands and the outcome of the Independent review of the bid to determine its fairness ?
Given the rising price of spodumene and the determination of where the price may be going given the expected demand , the reduction in the surplus world wide supplies one would have to assume that an Independent valuation would possibly come out higher than the current 18.8p on offer..does anyone think that the Chinese would anticipate and nudge the offer up or wait for the review and then act or just do nothing..the response of Assore would also be very interesting..we are in a slightly awkward position though as if the deal collapsed the Chinese would still have Elevra stake and spod supply so a little bit of an increase in price might be the best outcome if no white knight to the rescue !